We identified an AFR-specific protein-truncating variant in APOL3 (MAF of ~22% in individuals genetically similar to AFR used by gnomAD) that was significantly associated with increased risk of CKD and primarily increased CKD risk in monoallelic carriers of the APOL1 G1/G2 alleles. Here, APOL1 is linked to chronic kidney disease.